Publications by authors named "Manfred Groeppel"

Claim this Profile
C
Clinical relevance of intestinal barrier dysfunction in common gastrointestinal diseases.
Andreas Muehler, Jason R Slizgi, Hella Kohlhof, Manfred Groeppel, Evelyn Peelen

World J Gastrointest Pathophysiol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability and Pharmacokinetics of Vidofludimus calcium (IMU-838) After Single and Multiple Ascending Oral Doses in Healthy Male Subjects.
Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel Vitt

Eur J Drug Metab Pharmacokinet· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Selective Oral Immunomodulator Vidofludimus in Patients with Active Rheumatoid Arthritis: Safety Results from the COMPONENT Study.
Andreas Muehler, Hella Kohlhof, Manfred Groeppel, Daniel Vitt

Drugs R D· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease.
Leo R Fitzpatrick, Ludwig Deml, Claudia Hofmann, Jeffrey S Small, Manfred Groeppel

Inflamm Bowel Dis· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis